Krasuski, R. A., Tobore, T., Studer, S., Jansa, P., Sitbon, O., Hoeper, M. M., … Reardon, L. (2023). A Meta-analysis: Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD) Receiving PAH Medication. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (Vol. 207).

Krasuski, R. A., T. Tobore, S. Studer, P. Jansa, O. Sitbon, M. M. Hoeper, R. N. Channick, et al. “A Meta-analysis: Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD) Receiving PAH Medication.” In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 207, 2023.

Krasuski RA, Tobore T, Studer S, Jansa P, Sitbon O, Hoeper MM, et al. A Meta-analysis: Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD) Receiving PAH Medication. In: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2023.

Krasuski, R. A., et al. “A Meta-analysis: Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD) Receiving PAH Medication.” AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 207, 2023.

Krasuski RA, Tobore T, Studer S, Jansa P, Sitbon O, Hoeper MM, Channick RN, Gaine S, Lang IM, Chin KM, Pulido T, Mehta S, Torbicki A, Sastry B, Tang X, McLaughlin V, Reardon L. A Meta-analysis: Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD) Receiving PAH Medication. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2023.